Stanislav Glezer
Chief Tech/Sci/R&D Officer en INOGEN, INC. .
Fortuna: 129 975 $ al 31/03/2024
Perfil
El Dr. Stanislav Glezer es Director Médico y Vicepresidente Ejecutivo de Inogen, Inc. y Vicepresidente Mundial de Asuntos Médicos de Becton, Dickinson & Co. Forma parte del Consejo de Administración de la Diabetes Foundation of New Jersey. Anteriormente, el Dr. Glezer trabajó como Director Médico en Adocia SA y como Vicepresidente de Asuntos Médicos Mundiales en Novo Nordisk, Inc. Obtuvo un MBA en la California Coast University y un doctorado en la Yevdokimov MSUMD.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INOGEN, INC.
0.07% | 01/03/2024 | 16 106 ( 0.07% ) | 129 975 $ | 31/03/2024 |
Cargos activos de Stanislav Glezer
| Empresas | Cargo | Inicio |
|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 21/06/2021 |
| Diabetes Foundation of New Jersey | Director/Board Member | 24/07/2019 |
Antiguos cargos conocidos de Stanislav Glezer.
| Empresas | Cargo | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 01/06/2021 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2017 |
| Sanofi SA | Corporate Officer/Principal | - |
Formación de Stanislav Glezer.
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Empresas privadas | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Bolsa de valores
- Insiders
- Stanislav Glezer
